ParcelBio

San Francisco, United States

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

$13.2M raised

May 2026

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ParcelBio raised?

ParcelBio has raised $13.2M in total funding. The most recent round was Seed. The last funding was announced in May 2026.

Who are ParcelBio's investors?

ParcelBio's investors include General Catalyst, Alumni Ventures, Y Combinator, Pioneer Fund, ZAKA VC.

Where is ParcelBio headquartered?

ParcelBio is headquartered in San Francisco, United States.

What does ParcelBio do?

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

What stage is ParcelBio at?

ParcelBio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 7, 2026.

MLA

"ParcelBio — Funding & Investors." VCBacked, May 7, 2026, https://www.vcbacked.co/company/parcelbio. Accessed July 8, 2026.

APA

VCBacked. (2026). ParcelBio — Funding & Investors. Retrieved July 8, 2026, from https://www.vcbacked.co/company/parcelbio

Wikipedia (cite web)

{{cite web |title=ParcelBio — Funding & Investors |url=https://www.vcbacked.co/company/parcelbio |website=VCBacked |access-date=July 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 7, 2026.